 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization...

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case

Palumbo Wealth Management LLC bought a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and...

Palumbo Wealth Management LLC Buys New Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)

Organogenesis Holdings Inc. (NASDAQ:ORGO  Free Report)  Investment analysts at Cantor Fitzgerald reduced their FY2024 earnings estimates for Organogenesis in a research report issued...

Organogenesis Holdings Inc. (NASDAQ:ORGO) to Post FY2024 Earnings of $0.00 Per Share, Cantor Fitzgerald Forecasts

Swiss National Bank bought a new position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO  Free Report) during the 3rd quarter, according to its most recent 13F filing with the...

Swiss National Bank Invests $505,000 in Organogenesis Holdings Inc. (NASDAQ:ORGO)

Q4 2023 Organogenesis Holdings Inc Earnings Call Transcript

CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

Organogenesis Holdings Q4 2023 Earnings Preview...

Organogenesis Holdings Q4 2023 Earnings Preview

This is a Bullish indicator signaling ORGO's price could rise from here. Traders may explore going long the stock or buying call options...

Organogenesis Holdings (ORGO, $3.58) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 27, 2024

This indicator may be signaling that ORGO's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Organogenesis Holdings (ORGO, $3.38) entered Downtrend as Momentum indicator drops below 0 level on Feb 22, 2024

Organogenesis Holdings (ORGO, $3.43) entered Downtrend as Momentum indicator drops below 0 level on Feb 21, 2024

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Volume (M)	340,170.00
52-Wk High	$4.71
52-Wk Low	$1.80

ORGO Organogenesis Holdings Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals